1. Home
  2. ABCL vs CLMT Comparison

ABCL vs CLMT Comparison

Compare ABCL & CLMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABCL
  • CLMT
  • Stock Information
  • Founded
  • ABCL 2012
  • CLMT 1916
  • Country
  • ABCL Canada
  • CLMT United States
  • Employees
  • ABCL N/A
  • CLMT N/A
  • Industry
  • ABCL Biotechnology: Pharmaceutical Preparations
  • CLMT Oil & Gas Production
  • Sector
  • ABCL Health Care
  • CLMT Energy
  • Exchange
  • ABCL Nasdaq
  • CLMT Nasdaq
  • Market Cap
  • ABCL 1.1B
  • CLMT 1.2B
  • IPO Year
  • ABCL 2020
  • CLMT 2006
  • Fundamental
  • Price
  • ABCL $4.39
  • CLMT $15.95
  • Analyst Decision
  • ABCL Strong Buy
  • CLMT Strong Buy
  • Analyst Count
  • ABCL 5
  • CLMT 6
  • Target Price
  • ABCL $8.00
  • CLMT $20.38
  • AVG Volume (30 Days)
  • ABCL 5.5M
  • CLMT 847.1K
  • Earning Date
  • ABCL 08-07-2025
  • CLMT 08-08-2025
  • Dividend Yield
  • ABCL N/A
  • CLMT N/A
  • EPS Growth
  • ABCL N/A
  • CLMT N/A
  • EPS
  • ABCL N/A
  • CLMT N/A
  • Revenue
  • ABCL $32,875,999.00
  • CLMT $4,070,400,000.00
  • Revenue This Year
  • ABCL N/A
  • CLMT $1.02
  • Revenue Next Year
  • ABCL $71.11
  • CLMT $2.01
  • P/E Ratio
  • ABCL N/A
  • CLMT N/A
  • Revenue Growth
  • ABCL N/A
  • CLMT N/A
  • 52 Week Low
  • ABCL $1.89
  • CLMT $7.68
  • 52 Week High
  • ABCL $5.82
  • CLMT $25.29
  • Technical
  • Relative Strength Index (RSI)
  • ABCL 51.44
  • CLMT 58.76
  • Support Level
  • ABCL $4.01
  • CLMT $12.94
  • Resistance Level
  • ABCL $4.81
  • CLMT $14.49
  • Average True Range (ATR)
  • ABCL 0.36
  • CLMT 0.90
  • MACD
  • ABCL -0.05
  • CLMT 0.10
  • Stochastic Oscillator
  • ABCL 42.59
  • CLMT 88.53

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

About CLMT Calumet Specialty Products Partners L.P. Common Units

Calumet Inc is a producer of specialty products, including base oils, specialty oils, solvents, esters, and waxes, as well as a variety of fuel and fuel-related products, including asphalt and heavy fuel oils. The company manufactures, formulates, and markets a variety of specialty branded products to customers in various consumer-facing and industrial markets. Its segments include: Specialty Products and Solutions; Montana/Renewables; Performance Brands; and Corporate. The company generates maximum revenue from Fuels, asphalt and other by-products.

Share on Social Networks: